Opioid-Related Disorders

"Opioid-Related Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disorders related or resulting from abuse or mis-use of opioids.

Descriptor ID	D009293
MeSH Number(s)	C25.775.675 F03.900.675
Concept/Terms	Opioid-Related Disorders Opioid-Related Disorders Disorder, Opioid-Related Opioid Abuse Abuse, Opioid Abuses, Opioid Opioid Abuses Opiate Abuse Abuse, Opiate Abuses, Opiate Opiate Abuses Opiate Dependence Opiate Dependence Dependence, Opiate Opiate Addiction Addiction, Opiate

Below are MeSH descriptors whose meaning is more general than "Opioid-Related Disorders".

Diseases [C]
Chemically-Induced Disorders [C25]
Substance-Related Disorders [C25.775]
Opioid-Related Disorders [C25.775.675]
Psychiatry and Psychology [F]
Mental Disorders [F03]
Substance-Related Disorders [F03.900]
Opioid-Related Disorders [F03.900.675]

Below are MeSH descriptors whose meaning is related to "Opioid-Related Disorders".

Below are MeSH descriptors whose meaning is more specific than "Opioid-Related Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Opioid-Related Disorders" by people in this website by year, and whether "Opioid-Related Disorders" was a major or minor topic of these publications.

Bar chart showing 222 publications over 23 distinct years, with a maximum of 28 publications in 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	0	2
1997	2	1	3
2000	1	0	1
2002	1	0	1
2005	2	0	2
2006	1	1	2
2007	3	0	3
2008	4	2	6
2009	3	0	3
2010	4	1	5
2011	4	0	4
2012	5	0	5
2013	4	1	5
2014	12	1	13
2015	8	0	8
2016	14	2	16
2017	18	2	20
2018	18	2	20
2019	17	6	23
2020	25	2	27
2021	23	1	24
2022	28	0	28
2023	1	0	1

Below are the most recent publications written about "Opioid-Related Disorders" by people in Profiles.

Pivovarova E, Taxman FS, Boland AK, Smelson DA, Lemon SC, Friedmann PD. Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers. J Subst Use Addict Treat. 2023 Apr; 147:208950.

View in: PubMed
Harrington C, Bailey A, Delorme E, Hano S, Evans EA. "And Then COVID Hits": A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19. Subst Use Misuse. 2023; 58(2):266-274.

View in: PubMed
Punches BE, Stolz U, Freiermuth CE, Ancona RM, McLean SA, House SL, Beaudoin FL, An X, Stevens JS, Zeng D, Neylan TC, Clifford GD, Jovanovic T, Linnstaedt SD, Germine LT, Bollen KA, Rauch SL, Haran JP, Storrow AB, Lewandowski C, Musey PI, Hendry PL, Sheikh S, Jones CW, Kurz MC, Gentile NT, McGrath ME, Hudak LA, Pascual JL, Seamon MJ, Harris E, Chang AM, Pearson C, Peak DA, Merchant RC, Domeier RM, Rathlev NK, O'Neil BJ, Sanchez LD, Bruce SE, Pietrzak RH, Joormann J, Barch DM, Pizzagalli DA, Smoller JW, Luna B, Harte SE, Elliott JM, Kessler RC, Ressler KJ, Koenen KC, Lyons MS. Predicting at-risk opioid use three months after ed visit for trauma: Results from the AURORA study. PLoS One. 2022; 17(9):e0273378.

View in: PubMed
Randall A, Hull I, Martin SA. Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation. J Addict Med. 2023 Mar-Apr 01; 17(2):237-240.

View in: PubMed
Bosse JD, Hoffman K, Wiest K, Todd Korthuis P, Petluri R, Pertl K, Martin SA. Patient evaluation of a smartphone application for telehealth care of opioid use disorder. Addict Sci Clin Pract. 2022 09 09; 17(1):50.

View in: PubMed
Matsumoto A, Santelices C, Evans EA, Pivovarova E, Stopka TJ, Ferguson WJ, Friedmann PD. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts. Int J Drug Policy. 2022 11; 109:103823.

View in: PubMed
Zeliadt SB, Douglas JH, Gelman H, Coggeshall S, Taylor SL, Kligler B, Bokhour BG. Effectiveness of a whole health model of care emphasizing complementary and integrative health on reducing opioid use among patients with chronic pain. BMC Health Serv Res. 2022 Aug 17; 22(1):1053.

View in: PubMed
Jawa R, Walley AY, Wilson DJ, Green TC, McKenzie M, Hoskinson R, Bratberg J, Ramsey S, Rich JD, Friedmann PD. Prescribe to Save Lives: Improving Buprenorphine Prescribing Among HIV Clinicians. J Acquir Immune Defic Syndr. 2022 08 15; 90(5):546-552.

View in: PubMed
Stopka TJ, Rottapel RE, Ferguson WJ, Pivovarova E, Toro-Mejias LD, Friedmann PD, Evans EA. Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers. Int J Drug Policy. 2022 Dec; 110:103803.

View in: PubMed
Fiddian-Green A, Gubrium A, Harrington C, Evans EA. Women-Reported Barriers and Facilitators of Continued Engagement with Medications for Opioid Use Disorder. Int J Environ Res Public Health. 2022 07 30; 19(15).

View in: PubMed

People

Explore

Similar Concepts

Top Journals